Voxergolide (INNTooltip International Nonproprietary Name; developmental code name RU-41656) is a dopamine receptor agonist of the ergoline family described as an anti-anoxic and anti-ischemic agent which was never marketed.[1][2][3] It acts specifically as a dopamine D2 receptor agonist.[4][3]

References

  1. ^ Pharmaceutical Manufacturing Encyclopedia. Volumes 1-4. William Andrew Publishing. 2013. p. 3460. ISBN 978-0-8155-1856-3. Retrieved 23 February 2025.
  2. ^ Negwer M (1994). Organic-chemical Drugs and Their Synonyms: (an International Survey). Akad.-Verlag. p. 1179. ISBN 978-3-05-500156-7. Retrieved 23 February 2025.
  3. ^ a b Patat A, Klein MJ, Surjus A, Hucher M, Granier J (1991). "RU 41,656 does not reverse the scopolamine-induced cognitive deficit in healthy volunteers". European Journal of Clinical Pharmacology. 41 (3): 225–231. doi:10.1007/BF00315434. PMID 1684155.
  4. ^ Willig F, Van de Velde D, Laurent J, M'Harzi M, Delacour J (1992). "The Roman strains of rats as a psychogenetic tool for pharmacological investigation of working memory: example with RU 41656". Psychopharmacology. 107 (2–3): 415–424. doi:10.1007/BF02245169. PMID 1352059.
Allikas: https://en.wikipedia.org/wiki/Voxergolide
No tags for this post.